{"transactions":[{"id":754745,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-02T21:16:11.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":46600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest on May 29, 2027 subject to the continuous service of the optionee to the Issuer."}],"balance_after":46600,"derivative":{"exercise_price":7.01,"exercise_date":"2027-05-29","expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":46600},"source":{"system":"sec-edgar","filing":"0001658390-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000165839026000001/primarydocument.xml","form_type":"4"}},{"id":754744,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T21:16:11.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 29, 2027 subject to the continuous service of the\nrecipient to the Issuer."}],"balance_after":28861,"source":{"system":"sec-edgar","filing":"0001658390-26-000001","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000165839026000001/primarydocument.xml","form_type":"4"}},{"id":1124967,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-03T20:32:00.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":39815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer."}],"balance_after":39815,"derivative":{"exercise_price":8.85,"expiration_date":"2035-05-30","underlying":"Common Stock","underlying_shares":39815},"source":{"system":"sec-edgar","filing":"0001562180-25-004349","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218025004349/primarydocument.xml","form_type":"4"}},{"id":1124966,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-03T20:32:00.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":7768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2026 subject to the continuous service of the recipient to the Issuer."}],"balance_after":19054,"source":{"system":"sec-edgar","filing":"0001562180-25-004349","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218025004349/primarydocument.xml","form_type":"4"}},{"id":1492283,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-04T20:42:20.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":24454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer."}],"balance_after":24454,"derivative":{"exercise_price":14.35,"expiration_date":"2034-05-31","underlying":"Common Stock","underlying_shares":24454},"source":{"system":"sec-edgar","filing":"0001562180-24-004653","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218024004653/primarydocument.xml","form_type":"4"}},{"id":1492282,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T20:42:20.000Z","date":"2024-05-31","kind":"grant","planned":false,"acquired":true,"shares":4790,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer."}],"balance_after":11286,"source":{"system":"sec-edgar","filing":"0001562180-24-004653","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218024004653/primarydocument.xml","form_type":"4"}},{"id":1865179,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-06-06T21:12:21.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":17892,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer."}],"balance_after":17892,"derivative":{"exercise_price":19.72,"expiration_date":"2033-06-02","underlying":"Common Stock","underlying_shares":17892},"source":{"system":"sec-edgar","filing":"0001562180-23-004891","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218023004891/primarydocument.xml","form_type":"4"}},{"id":1865178,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T21:12:21.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":3486,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer."}],"balance_after":6496,"source":{"system":"sec-edgar","filing":"0001562180-23-004891","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218023004891/primarydocument.xml","form_type":"4"}},{"id":2240159,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-07T20:18:08.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":15324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest in 12 equal monthly installments following June 3, 2022 while the optionee provides continuous service to the Issuer."}],"balance_after":15324,"derivative":{"exercise_price":22.84,"expiration_date":"2032-06-03","underlying":"Common Stock","underlying_shares":15324},"source":{"system":"sec-edgar","filing":"0001562180-22-004876","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218022004876/primarydocument.xml","form_type":"4"}},{"id":2240158,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T20:18:08.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":3010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2023 while the recipient provides continuous service to the Issuer."}],"balance_after":3010,"source":{"system":"sec-edgar","filing":"0001562180-22-004876","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218022004876/primarydocument.xml","form_type":"4"}},{"id":2677590,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T20:19:08.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following June 4, 2021."}],"balance_after":10000,"derivative":{"exercise_price":35.52,"expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-21-004127","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218021004127/primarydocument.xml","form_type":"4"}},{"id":3127116,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T20:33:16.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 29, 2020."}],"balance_after":10000,"derivative":{"exercise_price":37.66,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-20-004065","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218020004065/primarydocument.xml","form_type":"4"}},{"id":3502463,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-04T20:19:51.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 31, 2019."}],"balance_after":10000,"derivative":{"exercise_price":43.02,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-19-003292","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218019003292/primarydocument.xml","form_type":"4"}},{"id":3914183,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-30T20:20:12.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over the 36 months following May 25, 2018, with immediate full vesting in the event of a change in control."}],"balance_after":25000,"derivative":{"exercise_price":49.45,"expiration_date":"2028-05-25","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-18-002712","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000156218018002712/primarydocument.xml","form_type":"4"}},{"id":4380135,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-03-17T15:53:24.000Z","date":"2017-03-15","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 16, 2015 and is scheduled to vest over four years with 25% of the shares having vested on March 9, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through March 9, 2019."}],"balance_after":30461,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-14","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001179110-17-004785","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000117911017004785/edgar.xml","form_type":"4"}},{"id":4380134,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-17T15:53:24.000Z","date":"2017-03-15","kind":"sale","acquired":false,"shares":1000,"price":26.41,"value":26410.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2016."}],"balance_after":117788,"source":{"system":"sec-edgar","filing":"0001179110-17-004785","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000117911017004785/edgar.xml","form_type":"4"}},{"id":4380133,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-03-17T15:53:24.000Z","date":"2017-03-15","kind":"exercise","acquired":true,"shares":1000,"price":0.65,"value":650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2016."}],"balance_after":118788,"source":{"system":"sec-edgar","filing":"0001179110-17-004785","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000117911017004785/edgar.xml","form_type":"4"}},{"id":4442714,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-16T23:39:19.000Z","date":"2017-02-15","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on April 16, 2015 and is scheduled to vest over four years with 25% of the shares having vested on March 9, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through March 9, 2019."}],"balance_after":31461,"derivative":{"exercise_price":0.65,"expiration_date":"2025-04-15","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001179110-17-002572","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000117911017002572/edgar.xml","form_type":"4"}},{"id":4442713,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-16T23:39:19.000Z","date":"2017-02-15","kind":"sale","acquired":false,"shares":1000,"price":23.4844,"value":23484.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2016."}],"balance_after":117788,"source":{"system":"sec-edgar","filing":"0001179110-17-002572","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000117911017002572/edgar.xml","form_type":"4"}},{"id":4442712,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-16T23:39:19.000Z","date":"2017-02-15","kind":"sale","acquired":false,"shares":5000,"price":20,"value":100000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2016."}],"balance_after":118788,"source":{"system":"sec-edgar","filing":"0001179110-17-002572","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000117911017002572/edgar.xml","form_type":"4"}},{"id":4442711,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":42390,"kind":"person","name":"Glucksmann Alexandra","position":1,"cik":"0001658390","reported_name":"Glucksmann Alexandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2017-02-16T23:39:19.000Z","date":"2017-02-15","kind":"exercise","acquired":true,"shares":6000,"price":0.65,"value":3900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on June 13, 2016."}],"balance_after":123788,"source":{"system":"sec-edgar","filing":"0001179110-17-002572","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1658390/000117911017002572/edgar.xml","form_type":"4"}}]}